title: Effects of luteinizing hormone and androgen on the development of rat progenitor Leydig cells in vitro and in vivo.
abstract: Progenitor Leydig cells are derived from stem cells. The proliferation and differentiation of progenitor Leydig cells significantly contributes to Leydig cell number during puberty. However, the regulation of these processes remains unclear. The objective of the present study was to determine whether luteinizing hormone (LH) or androgen contributes to the proliferation and differentiation of progenitor Leydig cells. Fourteen-day-old male Sprague-Dawley rats were treated for 7 days with NalGlu, which is a gonadotropin-releasing hormone antagonist, to reduce the secretion of LH in the pituitary and thus, androgen in the testis. Rats were co-administered with LH or 7α-methyl-nortestosterone (MENT), which is an androgen resistant to metabolism by 5α-reductase 1 in progenitor Leydig cells, and the subsequent effects of LH or androgen were measured. (3)H-Thymidine was also intravenously injected into rats to study thymidine incorporation in progenitor Leydig cells. Progenitor Leydig cells were examined. NalGlu administration reduced progenitor Leydig cell proliferation by 83%. In addition, LH or MENT treatment restored Leydig cell proliferative capacity to 73% or 50% of control, respectively. The messenger RNA levels of proliferation-related genes were measured using real-time PCR. The expression levels of Igf1, Lifr, Pdgfra, Bcl2, Ccnd3 and Pcna were upregulated by MENT, and those of Pdgfra, Ccnd3 and Pcna were upregulated by LH. Both LH and MENT stimulated the differentiation of progenitor Leydig cells in vitro. We concluded that both LH and MENT were involved in regulating the development of progenitor Leydig cells.
authors.affiliation: The 2nd Affiliated Hospital, Wenzhou Medical College, Wenzhou, China.
authors.forename: Jing-Jing
authors.initials: JJ
authors.lastname: Guo
authors.forename: Xue
authors.initials: X
authors.lastname: Ma
authors.forename: Claire Q F
authors.initials: CQ
authors.lastname: Wang
authors.forename: Yu-Fei
authors.initials: YF
authors.lastname: Ge
authors.forename: Qing-Quan
authors.initials: QQ
authors.lastname: Lian
authors.forename: Dianne O
authors.initials: DO
authors.lastname: Hardy
authors.forename: Yu-Fei
authors.initials: YF
authors.lastname: Zhang
authors.forename: Qiang
authors.initials: Q
authors.lastname: Dong
authors.forename: Yun-Fei
authors.initials: YF
authors.lastname: Xu
authors.forename: Ren-Shan
authors.initials: RS
authors.lastname: Ge
mesh_terms: D000728:Androgens / Q000096:biosynthesis / Q000494:pharmacology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007985:Leydig Cells / Q000166:cytology*; D007986:Luteinizing Hormone / Q000494:pharmacology*; D008297:Male; D009277:Nandrolone / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013234:Stem Cells / Q000166:cytology*
chemical_list: D000728:Androgens; C057805:LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-; D007987:Gonadotropin-Releasing Hormone; C064709:trestolone; D009277:Nandrolone; D007986:Luteinizing Hormone